stockrowGlaukos Corporation
GKOS Healthcare Medical Devices
Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024.
- Revenue
- +58.0%
- EPS
- +112.2%
- Free cash flow
- +411.2%
- Total debt
- −2.25%
Quarter to September 2026, against a year earlier
Follow GKOS
Alert me
Glaukos Corporation (GKOS) Revenue growth
Glaukos Corporation's revenue growth over the twelve months to 30 September 2026 was 46.9%, up 14.6 percentage points from fiscal 2025 (32.3%). Over the past ten years it has ranged from −5.07% (fiscal 2020) to 59.6% (fiscal 2016); the current reading is higher than 73% of that period. That is above the Medical Devices industry median of 10.4% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 32.3% | 10.48 |
| FY2024 | 21.9% | 10.59 |
| FY2023 | 11.3% | 15.05 |
| FY2022 | −3.79% | (34.49) |
| FY2021 | 30.7% | 35.77 |
| FY2020 | −5.07% | (35.80) |
| FY2019 | 30.7% | 16.90 |
| FY2018 | 13.8% | (25.38) |
| FY2017 | 39.2% | (20.34) |
| FY2016 | 59.6% | 2.27 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 58.0% | 8.49 |
| Jun 2026 | 49.5% | 8.38 |
| Mar 2026 | 41.2% | 5.50 |
| Dec 2025 | 35.7% | (2.48) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| GKOS Glaukos Corporation | 46.9% |
| PODD Insulet Corporation compare | 26.5% |
| PEN Penumbra, Inc. compare | 17.0% |
| GMED Globus Medical, Inc. compare | 13.4% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 6.98% |
| SNN Smith & Nephew SNATS, Inc. compare | 4.81% |
| BRKR Bruker Corporation compare | 2.16% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 1.38% |
| BIO Bio-Rad Laboratories, Inc. compare | 1.38% |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on GKOS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement